Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_assertion type Assertion NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_head.
- NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_provenance.
- NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_assertion evidence source_evidence_literature NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_provenance.
- NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_assertion SIO_000772 23589145 NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_provenance.
- NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_assertion wasDerivedFrom befree-2016 NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_provenance.
- NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_assertion wasGeneratedBy ECO_0000203 NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_provenance.